Drug Evaluation Committee Materials for "Toward Utilization in Drug Development: Opinion Exchange Meeting between Pharmaceutical Companies and Disease Registry Holders" (held on October 2, 2023)
Oct. 19, 2023
Presentation materials for "Toward Utilization in Drug Development: Opinion Exchange Meeting between Pharmaceutical Companies and Disease Registry Holders" (held on October 2, 2023), organized by Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA).
- 01_KT10SG1_Registry Opinion Exchange Meeting Program (396KB)
- 02_Registry Utilization for Drug Approval Applications, etc. - Organizing Issues Focusing on the Internal Processes of Companies - (1.21MB)
- 03_Remudy-DM_Mental_Disease_Registry（3.1MB)
- 04_Rare cancer MASTERKEY (3.12MB)
- 05_Protecting Intractable Disease Platform (1.95MB)